| Year |
Citation |
Score |
| 2020 |
Mohamed MF, Minocha M, Trueman S, Feng T, Enejosa J, Fisniku O, Othman AA. Characterization of the Effect of Upadacitinib on the Pharmacokinetics of Bupropion, a Sensitive Cytochrome P450 2B6 Probe Substrate. Clinical Pharmacology in Drug Development. PMID 32648334 DOI: 10.1002/Cpdd.844 |
0.345 |
|
| 2017 |
Polepally AR, Wang H, Marroum PJ, Minocha M, Hosmane B, Khatri A, Mensing S, Podsadecki TJ, Cohen DE, Awni WM, Menon RM. Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV Infection. The Aaps Journal. PMID 28685397 DOI: 10.1208/S12248-017-0115-3 |
0.311 |
|
| 2014 |
Vaishya RD, Gokulgandhi M, Patel S, Minocha M, Mitra AK. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis. Aaps Pharmscitech. 15: 1238-51. PMID 24895075 DOI: 10.1208/S12249-014-0100-4 |
0.756 |
|
| 2014 |
Khurana V, Minocha M, Pal D, Mitra AK. Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 249-59. PMID 24807167 DOI: 10.1515/dmdi-2014-0014 |
0.661 |
|
| 2014 |
Khurana V, Minocha M, Pal D, Mitra AK. Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors. Drug Metabolism and Drug Interactions. 29: 179-90. PMID 24643910 DOI: 10.1515/Dmdi-2013-0062 |
0.625 |
|
| 2014 |
Minocha M, Shukla S, Gobburu J. Integration of pharmacogenomics and pharmacometrics to support drug development, regulatory and therapeutic decisions Current Pharmacogenomics and Personalized Medicine. 12: 32-42. DOI: 10.2174/1875692112666140315005909 |
0.429 |
|
| 2012 |
Minocha M, Khurana V, Mitra AK. Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS). Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 901: 85-92. PMID 22749591 DOI: 10.1016/J.Jchromb.2012.06.004 |
0.603 |
|
| 2012 |
Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib. International Journal of Pharmaceutics. 436: 127-34. PMID 22688250 DOI: 10.1016/J.Ijpharm.2012.05.038 |
0.681 |
|
| 2012 |
Minocha M, Khurana V, Qin B, Pal D, Mitra AK. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors. International Journal of Pharmaceutics. 434: 306-14. PMID 22633931 DOI: 10.1016/J.Ijpharm.2012.05.028 |
0.671 |
|
| 2011 |
Minocha M, Mandava NK, Kwatra D, Pal D, Folk WR, Earla R, Mitra AK. Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats. International Journal of Pharmaceutics. 413: 44-50. PMID 21545833 DOI: 10.1016/J.Ijpharm.2011.04.051 |
0.687 |
|
| 2011 |
Pal D, Kwatra D, Minocha M, Paturi DK, Budda B, Mitra AK. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sciences. 88: 959-71. PMID 20932495 DOI: 10.1016/J.Lfs.2010.09.012 |
0.609 |
|
| 2010 |
Mandava N, Oberoi R, Minocha M, Mitra A. Transporter targeted drug delivery Journal of Drug Delivery Science and Technology. 20: 89-99. DOI: 10.1016/S1773-2247(10)50012-1 |
0.752 |
|
| 2010 |
Mitra A, Mitra A, Pal D, Minocha M, Kwatra D. Compatibility risks between drugs and herbal medicines or botanical supplements Toxicology Letters. 196: S17. DOI: 10.1016/J.Toxlet.2010.03.086 |
0.746 |
|
| 2010 |
Mandava N, Oberoi RK, Minocha M, Mitra AK. Transporter targeted drug delivery Journal of Drug Delivery Science and Technology. 20: 89-99. |
0.45 |
|
| 2009 |
Hariharan S, Minocha M, Mishra GP, Pal D, Krishna R, Mitra AK. Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. 25: 487-98. PMID 20028257 DOI: 10.1089/Jop.2009.0049 |
0.679 |
|
| Show low-probability matches. |